We are grateful to Research2Guidance and Stela Nikolova for facilitating an enlightening interview with Lorenzo Consoli. This conversation offered a deep dive into the founding of NuvoAir Medical and the intricacies involved in transitioning the business from Europe to the U.S. Lorenzo shared an inspiring narrative, shedding light on the pivotal business model transformations essential for NuvoAir to thrive within the U.S. healthcare ecosystem.
How moving to the US completely changed the business model of NuvoAir Medical? An #interview with Lorenzo Consoli, Founder and CEO https://bit.ly/3IOZa50 Chronic respiratory diseases affect approximately 500 million individuals worldwide and are often linked with heart failure. In the United States, #COPD and Chronic Heart Failure (#CHF) alone account for a combined annual cost exceeding $100 billion. In light of this significant impact, in a candid conversation with Lorenzo, we explored ✔️ How did the company transition from Europe to the U.S. market, and what led to the adoption of a new #businessmodel focused on value-based specialty care for managing complex cardiopulmonary conditions? ✔️ How does the platform foster seamless coordination among different healthcare stakeholders, ultimately streamlining #patientcare and enhancing #outcomes? ✔️ What advanced technologies in care does the company utilize, from #AI-powered analytics to the #FDA-cleared Air Next spirometer, to redefine in-home patient monitoring and intervention? ✔️ What are some of the recent #strategicpartnerships that help the company's growth and development? ✔️ Lessons learned from moving the business from Europe to the USA! ✔️ What lies ahead for NuvoAir Medical? Cary Medical Management, Security Health Plan, NHS were mentioned during the interview. 📌 Enjoy the interview: https://bit.ly/3IOZa50 #globalhealth #digitalhealth #cardiopulmonaryconditions #lunghealth #COPD #Asthma